Reaction mass of sodium trimethylsilanolate and tetrahydrofuran
|
944-284-2
|
|
Flam. Liq. 2
Acute Tox. 4
Skin Corr. 1C
Acute Tox. 4
Carc. 2
|
Notified C&L
|
View details
|
Reaction mass of 1-isopropyl-4-methylenebicyclo[3.1.0]hexan-3-hydroperoxide and 4-hydroperoxy-1-isopropyl-4-methylbicyclo[3.1.0]hex-2-ene and pin-2(3)-ene
|
944-285-8
|
|
Flam. Liq. 2
Org. Perox. B
Skin Sens. 1
Eye Irrit. 2
|
REACH registration C&L
|
View details
|
Reaction mass of 3-(Acryloyloxy)-2-hydroxypropyl methacrylate, 2-(Acryloyloxy)-3-hydroxypropyl methacrylate and 2,3-Bis(acryloyloxy)propyl methacrylate
|
944-287-9
|
|
Acute Tox. 4
Skin Irrit. 2
Skin Sens. 1A
Eye Dam. 1
Carc. 1B
|
REACH registration C&L
|
View details
|
N-alpha-(9-Fluorenylmethyloxycarbonyl)-N'-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-argininol
|
813-771-0
|
213336-24-4
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
Reaction mass of trisodium 2-(hydroxyphosphinato)succinate and pentasodium 1-(hydroxyphosphinato)butane-1,2,3,4-tetracarboxylate
|
701-079-0
|
|
|
REACH registration C&L
|
View details
|
(E)-2-Methoxy-4-prop-1-en-1-ylphenyl acetate
|
813-782-0
|
5912-87-8
|
|
REACH registration C&L
|
View details
|
[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid):2,6-diaminohexanoic acid, monohydrate
|
813-772-6
|
1263639-16-2
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Acute Tox. 4
Repr. 2
|
Notified C&L
|
View details
|
(1,3-Dichloro-isopropyl)-2-ethylhexylphthalat
|
813-773-1
|
2044017-79-8
|
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
(1,3-Dichloro-isopropyl)-isobutylphthalat
|
813-774-7
|
2044710-66-7
|
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
3-(3-Fluorophenyl)-1H-pyrazol-5-amine
|
813-775-2
|
766519-89-5
|
|
Notified C&L
|
View details
|
N-(3-(5-chloro-2-(difluoromethoxy)phenyl)-polyheterocycle-1H/8 4-pyrazolo[1,5-a]pyrimidine-3-carboxamide)
|
|
|
|
Notified C&L
|
View details
|
1-((2R,4R)-2-(1H-benzo[d]iMidazol-2-yl)-1-Methylpiperidin-4-yl)-3-(4-cyanophenyl)urea
|
813-776-8
|
1095173-27-5
|
|
Notified C&L
|
View details
|
5-Bromo-1H-1,3-benzodiazol-2-amine
|
813-777-3
|
791595-74-9
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
4,4,5,5-Tetramethyl-2-(2-methyl-3-nitrophenyl)-1,3,2-dioxaborolane
|
813-778-9
|
910235-64-2
|
|
Notified C&L
|
View details
|
3-Bromo-1H-pyrazol-5-amine
|
813-779-4
|
950739-21-6
|
|
Notified C&L
|
View details
|
Hexanedioic acid, polymer with 5,10,15-trimethyl-4,7,13,16-tetraoxa-10-azanonadecane-2,18-diol, reaction products with N-[3-(dimethylamino)propyl]-3-phenyl-2-propenamide and epichlorohydrin, chlorides methanesulfonates (salts)
|
813-781-5
|
397297-15-3
|
Skin Irrit. 2
Eye Irrit. 2
|
Notified C&L
|
View details
|
Reaction product of Propanoic acid, 3-[[bis(2-methylpropoxy)phosphinothioyl]thio]-2-methyl- and tridecanamine, N-tridecyl-, branched and linear
|
944-290-5
|
|
Skin Irrit. 2
Skin Sens. 1B
STOT RE 2
|
REACH registration C&L
|
View details
|
(1Z,5Z)-cycloocta-1,5-diene;[3-(4-diphenylphosphanyl-2,6-dimethoxypyridin-3-yl)-2,6-dimethoxypyridin-4-yl]-diphenylphosphane;rhodium;tetrafluoroborate
|
813-783-6
|
573718-56-6
|
|
Notified C&L
|
View details
|
tetrasodium;[dichloro(phosphonato)methyl]-[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-oxidophosphoryl]oxyphosphinate
|
813-784-1
|
163706-36-3
|
|
Notified C&L
|
View details
|
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide
|
813-785-7
|
1139453-98-7
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
Ethyl (1RS,6RS)-6-(dimethylamino)-3,6-dihydrobiphenyl-1(2H)-carboxylate hemi-naphthalene-1,5-disulfonate
|
813-786-2
|
32485-70-4
|
Acute Tox. 4
Eye Irrit. 2
Aquatic Chronic 3
|
Notified C&L
|
View details
|
Reaction products of diazotised 2-amino-5-nitrobenzenesulfonic acid coupled with resorcinol, subsequently coupled with diazotized 2-amino-4-nitro-6-sulfo-phenol, chelated with iron, hydrogen sodium salts
|
944-296-8
|
|
|
REACH registration C&L
|
View details
|
1-azabicyclo[2.2.2]octan-3-amine
|
813-787-8
|
6238-14-8
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
REACH registration C&L
|
View details
|
Spiro[piperidine-1,1'-pyrrolidinium] bifluoride
|
813-788-3
|
1803551-73-6
|
Skin Corr. 1A
Aquatic Chronic 3
|
REACH registration C&L
|
View details
|
(2Z)-2-fluoro-3-(morpholin-4-yl)prop-2-enal
|
813-789-9
|
152873-67-1
|
Eye Irrit. 2
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
Reaction mass of 1-(3,3-dimethylcyclohexyl)ethanone and 2,6,6-trimethylcycloheptanone
|
944-298-9
|
|
Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
(2S)-Pyrrolidine-2-carbonitrile; 2,2,2-trifluoroacetic acid
|
813-792-5
|
473797-71-6
|
|
Notified C&L
|
View details
|
Poly(dimethylsiloxane), monomethacryloxypropyl, monomethyl terminated
|
813-793-0
|
308072-61-9
|
Skin Sens. 1
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Reaction mass of 3-[3-(1,1,1,3,5,5,5-heptamethyltrisiloxan-3-yl)propoxy]-2-hydroxypropyl methacrylate and 1-[3-(1,1,1,3,5,5,5-heptamethyltrisiloxan-3-yl)propoxy]-3-hydroxypropan-2-yl methacrylate.
|
944-299-4
|
|
Skin Sens. 1
Aquatic Chronic 4
|
Notified C&L
|
View details
|
1-isocyanatomethyl-4-(2-methylpropoxy)benzene
|
813-794-6
|
639863-75-5
|
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
Resp. Sens. 1
STOT SE 3
|
Notified C&L
|
View details
|
1,3-Butadiene, homopolymer, (2-hydroxymethylethyl-terminated
|
813-795-1
|
849488-43-3
|
|
Notified C&L
|
View details
|
Trifluoromethylsulfanyl-acetic acid ethyl ester
|
813-796-7
|
80783-58-0
|
|
Notified C&L
|
View details
|
5-chloro-2,3-diphenylpyrazine
|
813-797-2
|
41270-66-0
|
|
Notified C&L
|
View details
|
5,6-Diphenyl-2-hydroxypyrazine
|
813-798-8
|
18591-57-6
|
|
Notified C&L
|
View details
|
4-((5,6-Diphenyl-Pyrazin-2-yl)(isopropyl)amino)butan-1-ol
|
813-799-3
|
475086-75-0
|
|
Notified C&L
|
View details
|
2-Bromo-N-Methylsulfonylacetamide
|
813-800-7
|
59504-75-5
|
|
Notified C&L
|
View details
|
2-Bromo-N-(2-Bromoacetyl)Acetamide
|
813-801-2
|
90586-97-3
|
|
Notified C&L
|
View details
|
3,3,5-Trimethylheptane
|
813-802-8
|
7154-80-5
|
|
Notified C&L
|
View details
|
2,4,6-trimethylheptane
|
813-803-3
|
2613-61-8
|
Flam. Liq. 3
Skin Irrit. 2
Eye Irrit. 2A
STOT SE 3
|
Notified C&L
|
View details
|
3,4,5-Trimethylheptane
|
813-804-9
|
20278-89-1
|
|
Notified C&L
|
View details
|
Hexane, 1,6-diisocyanato-, homopolymer, acrylic acid-polyethylene glycol ether with trimethylolpropane (3:1) reaction products- and 2-hydroxyethyl acrylate-blocked
|
944-302-9
|
|
Skin Irrit. 2
Skin Sens. 1
Eye Irrit. 2
|
Notified C&L
|
View details
|
3-Chloro-5-methylaniline
|
813-805-4
|
29027-20-1
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
Alcohols, C14-15-branched and linear, ethoxylated
|
813-807-5
|
120944-68-5
|
Acute Tox. 4
Eye Irrit. 2
Aquatic Chronic 3
|
Notified C&L
|
View details
|
1-(3-bromo-2-fluorophenyl)ethan-1-one
|
813-808-0
|
161957-61-5
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
4-Hydroxy-3-methoxybenzotrifluoride
|
813-809-6
|
1027888-79-4
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
1H-BenziMidazole, 4-fluoro-2-Methyl-1-(1-Methylethyl)-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-
|
813-810-1
|
1231930-37-2
|
|
Notified C&L
|
View details
|
1-[([[(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]oxy]carbonyl)oxy]pyrrolidine-2,5-dione
|
813-811-7
|
253265-97-3
|
Acute Tox. 4
Skin Sens. 1B
Eye Dam. 1
Muta. 2
Repr. 2
|
REACH registration C&L
|
View details
|
Cyclohexasilane
|
813-812-2
|
291-59-8
|
|
Notified C&L
|
View details
|
Dihydro-2H-pyran-3(4H)-one
|
813-813-8
|
23462-75-1
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
2-methyl-m-phenylene diisocyanate polymer with poly(oxy-1,2-ethanediyl), α-(1-oxo-2-propenyl)-.omega.-hydroxy, poly(oxy-1,2-ethanediyl), á-methyl-ù-hydroxy, 2,2',2''-nitrilotriethanol
|
944-303-4
|
|
Skin Irrit. 2
Eye Irrit. 2
|
Notified C&L
|
View details
|
|
|
|
|
|
|